BFT

Body Fit Training Cements Global Strength with Opening of 300th Studio in Spain

Retrieved on: 
Tuesday, April 2, 2024

Body Fit Training (BFT), the global boutique fitness brand offering 50-minute group strength training classes led by highly accredited coaches, announced today the opening of its 300th global studio in Barcelona, Spain.

Key Points: 
  • Body Fit Training (BFT), the global boutique fitness brand offering 50-minute group strength training classes led by highly accredited coaches, announced today the opening of its 300th global studio in Barcelona, Spain.
  • “Our 300th studio opening marks an important milestone for BFT.
  • To continue fueling this rapid growth in North America, Duncan Cork has been appointed as the new President of Body Fit Training.
  • “Body Fit Training is best-in-class when it comes to strength training and boutique fitness, and I am looking forward to ushering in the brand’s next phase of growth and evolution as President,” said Cork.

Blueshift Nutrition to Supply their Innovative Superblends to Xponential Fitness Brands, Powering Workouts and Wellness Across their Leading Fitness Brands

Retrieved on: 
Tuesday, March 19, 2024

Blueshift is excited to offer its innovative drinkable supplements to help studio members get the most from their workouts while also supporting general wellness goals.

Key Points: 
  • Blueshift is excited to offer its innovative drinkable supplements to help studio members get the most from their workouts while also supporting general wellness goals.
  • Awards included Favorite Sports Nutrition Product (Blueshift Electrolyte), Best New Supplement (Blueshift Turmeric), and Favorite Functional Beverage (Blueshift Sleep).
  • A comprehensive selection of Blueshift Superblends is now available at participating Xponential studio locations, ranging from their performance offerings to wellness solutions like sleep, energy, immunity, skin support, and more.
  • Paal Gisholt, CEO of Blueshift Nutrition, expressed enthusiasm about the partnership, saying, “We are thrilled to be partnering with Xponential to bring our Superblends to their diverse community of fitness enthusiasts in the United States.

New Lithium Sampling Tool Will Help Find More Lithium, And Produce More From Known Lithium Brine Resources

Retrieved on: 
Tuesday, March 5, 2024

The advanced tool can analyze fluid underground in real-time and capture multiple clean lithium brine samples from a well, for further testing.

Key Points: 
  • The advanced tool can analyze fluid underground in real-time and capture multiple clean lithium brine samples from a well, for further testing.
  • It was making it hard to find new lithium brine resources and to bring more lithium to market.
  • “The BFT was built to address the specific challenges of aquifer testing and fluid sampling in lithium brine exploration and production.
  • Zelandez’s BFT serves the testing and sampling needs of the lithium brine, groundwater, hard rock, coal seam gas, natural hydrogen, and helium sectors.

Orca Bio Presents Promising Data on Orca-T in Two Oral Presentations at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

Retrieved on: 
Friday, February 23, 2024

In the first of two oral presentations, findings from a retrospective analysis compared historical outcomes between Orca-T and a standard of care allogeneic stem cell transplant (alloHSCT) plus post-transplant cyclophosphamide (PTCy)-based graft versus host disease (GvHD) prophylaxis in patients with hematologic malignancies receiving myeloablative conditioning (MAC).

Key Points: 
  • In the first of two oral presentations, findings from a retrospective analysis compared historical outcomes between Orca-T and a standard of care allogeneic stem cell transplant (alloHSCT) plus post-transplant cyclophosphamide (PTCy)-based graft versus host disease (GvHD) prophylaxis in patients with hematologic malignancies receiving myeloablative conditioning (MAC).
  • Within the non-randomized cohorts of varying conditioning regimens and disease types, Orca-T demonstrated favorable results across clinical outcomes including relapse-free survival (RFS), non-relapse mortality (NRM) and overall survival (OS).
  • The analysis included patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) who had a median follow-up time of 15 months and 12 months in the Orca-T and PTCy cohorts, respectively.
  • The outcomes at 12 months are summarized in the table below:

WiMi Announced MHConsensus Blockchain Algorithm Achieving Efficient Data Management

Retrieved on: 
Friday, February 16, 2024

BEIJING, Feb. 16, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced an improved HBFT blockchain consensus algorithm for blockchains with multiple independent functions, namely "MHConsensus algorithm".

Key Points: 
  • BEIJING, Feb. 16, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced an improved HBFT blockchain consensus algorithm for blockchains with multiple independent functions, namely "MHConsensus algorithm".
  • The algorithm aims to achieve more efficient data management and election strategies, and to provide a reliable distributed consistency algorithm to cope with Byzantine faults that may occur in distributed systems.
  • To address this challenge, WiMi proposed the MHConsensus algorithm, which is designed to ensure that the system can still reach a unanimous consensus in the presence of a Byzantine fault.
  • WiMi believes that the MHConsensus algorithm has a huge role to play in transactions to ensure consistency and security of transactions.

WiMi is Working on a New Mixed Byzantine Fault Tolerant (MBFT) Algorithm to Enhance Blockchain Fault Tolerance

Retrieved on: 
Tuesday, January 16, 2024

Beijing, Jan. 16, 2024 (GLOBE NEWSWIRE) -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it is working on a novel mixed byzantine fault tolerance (MBFT).

Key Points: 
  • Beijing, Jan. 16, 2024 (GLOBE NEWSWIRE) -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it is working on a novel mixed byzantine fault tolerance (MBFT).
  • MBFT has its origins in the PBFT algorithm, the first consensus algorithm used in the Union Blockchain, but in many ways, MBFT has improved and innovated.
  • In addition, MBFT introduces a random node selection mechanism and a credit mechanism to further enhance its security and fault tolerance.
  • MBFT algorithm can reduce blockchain forks while ensuring high fault tolerance and speed.

CRYPTOBLOX PROVIDES YEAR END SUMMARY AND CORPORATE UPDATE

Retrieved on: 
Wednesday, January 3, 2024

Vancouver, B.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- CryptoBlox Technologies Inc. (the “Company” or “CryptoBlox”) (CSE: BLOX) wishes everyone a Happy New Year and is pleased to provide a corporate update summarizing the progress and developments in 2023, which focused on CryptoBlox building its diversified Blockchain Ecosystem Strategy (the “Blockchain Ecosystem Strategy”).

Key Points: 
  • Vancouver, B.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- CryptoBlox Technologies Inc. (the “Company” or “CryptoBlox”) (CSE: BLOX) wishes everyone a Happy New Year and is pleased to provide a corporate update summarizing the progress and developments in 2023, which focused on CryptoBlox building its diversified Blockchain Ecosystem Strategy (the “Blockchain Ecosystem Strategy”).
  • The strategic nature of this acquisition allows CryptoBlox to further align with its goal of reducing greenhouse gas emissions from digital asset mining.
  • By integrating all 3 layers together, CryptoBlox aims to enhance operational efficiency and create synergies across various aspects of the company's offerings.
  • Finally, in a strategic move to remain focused on the Company’s new vision and strategy, CryptoBlox has sold all non-blockchain/crypto related assets.

LBank Exchange Amplifies Web3 and DeFi Capabilities with Ethereal (ETRL) on December 15, 2023

Retrieved on: 
Monday, December 11, 2023

Users of LBank Exchange can brace themselves for the ETRL/USDT trading pair, which will go live at 8:00 UTC on the slated date.

Key Points: 
  • Users of LBank Exchange can brace themselves for the ETRL/USDT trading pair, which will go live at 8:00 UTC on the slated date.
  • LBank Exchange is thrilled to announce the upcoming listing of Ethereal (ETRL), an innovative Layer-1 blockchain platform designed to accelerate the adoption and scalability of Web3 applications.
  • This combination allows developers to effortlessly create and deploy decentralized applications (dApps), games, DeFi protocols, and various scaling solutions.
  • These features ensure that Ethereal not only supports a wide range of applications and services but also remains adaptable and inclusive.

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting

Retrieved on: 
Saturday, December 9, 2023

The results presented at the 65th American Society of Hematology (ASH) Annual Meeting showed promising data with the use of Orca Bio’s cell therapies across several patient groups where there is significant unmet medical need.

Key Points: 
  • The results presented at the 65th American Society of Hematology (ASH) Annual Meeting showed promising data with the use of Orca Bio’s cell therapies across several patient groups where there is significant unmet medical need.
  • Results highlighted in an oral presentation showed Orca-T’s ability to deliver similar outcomes in older patients undergoing myeloablative conditioning (MAC) as younger patients.
  • In this subgroup from the ongoing multi-center Phase 1b clinical trial, Orca-T demonstrated promising results in this patient population (n=16).
  • The estimated incidence of CTCAE grade 2 and greater than grade 3 infections at one year were 9% and 15%, respectively.

Commercial Aviation And Military Headset Market to grow by USD 362.9 million during 2022-2027 | Emphasis on better battlefield communications to drive the growth - Technavio

Retrieved on: 
Wednesday, November 29, 2023

NEW YORK, Nov. 28, 2023 /PRNewswire/ -- The commercial aviation and military headset market size is expected to grow by USD 362.9 million between 2022 and 2027.

Key Points: 
  • NEW YORK, Nov. 28, 2023 /PRNewswire/ -- The commercial aviation and military headset market size is expected to grow by USD 362.9 million between 2022 and 2027.
  • The market is segmented by Application (Military headset and Commercial aviation headset), Type (On-ear and In-ear), and Geography (North America, Europe, APAC, Middle East and Africa, and South America).
  • The emphasis on better battlefield communications drives market growth.
  • The use of low-grade pilot headsets challenges the commercial aviation and military headset market growth.